Turkey Pharmaceuticals & Healthcare Report Q2 2018
Turkey's pharmaceuticals and healthcare markets are set for robust growth over the long term, outperforming themajority of its regional peers. Continued growth in public spending will support market growth, driven by the Health TransformationPlan. However, we highlight that macro risks will increasingly place downside risks to this expansionary fiscal outlook, leading togrowth deceleration over the long term. Moreover, innovative drugmakers will remain averse to the high degree of risks inherent inthe market from localisation and pricing policies.
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.Download eBook